XML 12 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 126,800 $ 9 $ 955,657 $ 261 $ (829,127)
Beginning balance (in shares) at Dec. 31, 2024   99,085,888      
Vesting of restricted stock units   906,712      
Stock-based compensation 8,351   8,351    
Unrealized loss on marketable securities (70)     (70)  
Net loss (40,471)       (40,471)
Ending balance at Mar. 31, 2025 94,610 $ 9 964,008 191 (869,598)
Ending balance (in shares) at Mar. 31, 2025   99,992,600      
Beginning balance at Dec. 31, 2025 $ 30,649 $ 11 1,002,528 166 (972,056)
Beginning balance (in shares) at Dec. 31, 2025 110,362,581 110,362,581      
Exercise of stock options $ 25   25    
Exercise of stock options (in shares)   21,375      
Vesting of restricted stock units   641,231      
Stock-based compensation 2,908   2,908    
Unrealized loss on marketable securities (270)     (270)  
Net loss (22,930)       (22,930)
Ending balance at Mar. 31, 2026 $ 10,382 $ 11 $ 1,005,461 $ (104) $ (994,986)
Ending balance (in shares) at Mar. 31, 2026 111,025,187 111,025,187